Fate Therapeutics Inc
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat multiple myeloma; FT819 to treat hematologic malignancies and solid tumors; FT536 to treat solid tumors; and FT500 for the treatment of advanced solid tumors. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of two off-the-shelf iPSC-derived CAR T-cell product candidates; strategic research collaboration and license agreement with Juno Therapeutics, Inc. to screen for and identify small molecule modulators that enhance the therapeutic properties of genetically-engineered T-cell immunotherapies; and a collaboration and option agreement with Janssen Biotech, Inc. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California. Show More...
-
Website https://www.fatetherapeutics.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 1.10 EUR
-
Last Updated 29-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -1.51 -1.61 -3.54 -1.27 -1.18 -1.05 -1.02 -1.19 -1.44 -1.58 Dividends USD Payout Ratio % * Shares Mil 9.0 9.0 6.0 20.0 25.0 32.0 42.0 56.0 68.0 71.0 Book Value Per Share * EUR -2.36 1.34 1.43 0.58 0.73 2.35 3.17 2.55 Free Cash Flow Per Share * EUR -0.55 -0.86 -0.74 -0.95 -0.72 -0.69 -1.02 Return on Assets % -171.0 -151.8 -62.69 -48.48 -50.34 -41.06 -42.88 -41.84 -38.09 -41.24 Financial Leverage (Average) 1.09 1.81 1.79 1.3 1.36 1.33 1.24 1.47 Return on Equity % -65.37 -90.37 -60.19 -57.14 -56.05 -48.44 -61.31 Return on Invested Capital % -42.71 -53.3 -45.62 -50.4 -49.74 -45.07 -48.04 Interest Coverage -104.72 -28.24 -25.25 -46.15 -12.51 -19.44 -32.87 -38.27 -55.02 Current Ratio 1.82 2.02 11.88 10.89 4.88 6.14 9.29 7.53 8.17 8.36 Quick Ratio 1.73 1.87 11.74 10.72 4.82 6.07 9.14 7.39 7.96 8.16 Debt/Equity 0.64 0.28 0.03 0.19 0.08 0.1 0.34